Medtronic's (MDT) Prelim. Q4 Revenue Tops Views; FY16 Outlook, Covidient Integration Now in Focus - BTIG
Tweet Send to a Friend
BTIG affirms Medtronic plc (NYSE: MDT) with a Neutral rating following preliminary Q4 and FY15 results issued earlier.Medtronic's Q4 revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
